Search

THE VILLAGES, Fla., Oct. 25, 2024 /PRNewswire/ -- K2 Medical Research is proud to announce a significant milestone in the fight against Alzheimer's disease: the successful randomization of the first [...]

Vesalio Introduces pVasc(TM) U.S. clinical study initiative to capture real-world data and optimize results for patients suffering from peripheral vascular disease PLANO, Texas, Oct. 25, 2024 /PRNewswire/ -- Vesalio, a [...]

In first dedicated study of a selective IL-13 inhibitor in patients previously treated with dupilumab, the majority of patients had a history of inadequate response to dupilumab EBGLYSS also provided [...]

Study site selection and finalization of clinical trial agreement final step toward initiation of RVL-001 proof-of-concept clinical studies early next year BOSTON, Oct. 24, 2024 /PRNewswire/ -- Unravel Biosciences, Inc., [...]

LONDON, Oct. 24, 2024 /PRNewswire/ -- Coronado Research announced today that Professor Jennifer Visser-Rogers has been appointed as Chief Scientific Officer. Jennifer brings with her a broad portfolio of scientific [...]

Enables ATX-559 Phase 1 study in solid tumor patients with a focus on BRCA1/2-deficient breast cancer and solid tumors with microsatellite instability (MSI-H) and/or deficient mismatch repair (dMMR); first patient [...]

This randomized controlled study demonstrates that patients achieved a higher percentage of target hemoglobin levels Patients receiving anemia management assistance via the software tools saw a 25% reduction in erythropoiesis-stimulating [...]

Ribociclib (Kisqali) plus aromatase inhibitor (AI) recommended for HR+/HER2- early breast cancer (EBC) node-positive and high-risk node-negative patients, as studied in the NATALEE trial and indicated by the FDA[sup.1] Recommendation [...]

STOCKHOLM, Oct. 24, 2024 /PRNewswire/ --BioArctic AB's (publ)(Nasdaq Stockholm: BIOA B)founder Lars Lannfelt will be presented with the Lifetime Achievement Award in Alzheimer's Disease Therapeutic Research at the Clinical Trials [...]

SEOUL, South Korea, Oct. 24, 2024 /PRNewswire/ -- J INTS BIO, a pioneering biopharmaceutical company, has unveiled promising interim results from the Phase 1/2 clinical trial of its novel 4th-generation [...]

TOKYO, Oct. 23, 2024 /PRNewswire/ -- Eisai Co. Ltd (Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai') announced today that the company will present the latest findings on its Alzheimer's disease (AD) [...]

Data unveils new insights into treatment for type 2 diabetes, obesity, cardiovascular, kidney and liver diseases Cardiometabolic diseases, including cardiovascular disease, obesity, type 2 diabetes, and MASH, are increasing in [...]

EVANSTON, Ill., Oct. 23, 2024 /PRNewswire/ -- During National Massage Therapy Awareness Week, the https://c212.net/c/link/?t=0&l=en&o=4285334-1&h=2596287386&u=https%3A%2F%2Fwww.amtamassage.org%2F&a=American+Massage+Therapy+Association+(AMTA) is sharing a recent wave of research https://c212.net/c/link/?t=0&l=en&o=4285334-1&h=2563882668&u=https%3A%2F%2Fwww.amtamassage.org%2Fresources%2Fmassage-and-health%2Fmedical-treatments%2Fpregnancy-and-massage%2F&a=highlighting+the+benefits+of+massage+therapy+throughout+pregnancy+and+labor. These studies demonstrate how massage therapy can [...]

DENVER and SAN DIEGO, Oct. 23, 2024 /PRNewswire/ -- DaVita Clinical Research (DCR), a leading innovator in kidney care research and wholly owned subsidiary of DaVita Inc., will present the [...]

In this free webinar, learn about the technical factors involved in transitioning drug products, including material compatibility, process parameters and their effects on drug stability and integrity. Attendees will gain [...]

Series C led by Lightspeed Venture Partners and Ascenta Capital with participation from top-tier new investor syndicate and existing investors Funding will advance distinctive pipeline of targeted radiopharmaceuticals through clinical [...]

SAN FRANCISCO, Oct. 22, 2024 /PRNewswire/ -- This fall, leading experts from https://c212.net/c/link/?t=0&l=en&o=4283595-1&h=412273546&u=https%3A%2F%2Fpicnichealth.com%2F&a=PicnicHealth will present innovative solutions for observational research at top industry events. Speakers will share practical strategies and [...]

EQBMED is a collaborative, community-based partnership to address diversity in clinical trials supported by grant funding from PhRMA NEW HAVEN, Conn., Oct. 22, 2024 /PRNewswire/ -- Equitable Breakthroughs in Medicine [...]

Arcwell is a free, open-source platform designed to accelerate the development of clinical trials and wellness protocols by providing out-of-the-box tools. Already successfully implemented at two major hospitals, Arcwell helps [...]

CHOP Hematology Chief has been elected to the prestigious organization PHILADELPHIA, Oct. 21, 2024 /PRNewswire/ -- A renowned hematology expert from https://c212.net/c/link/?t=0&l=en&o=4282943-1&h=236092101&u=http%3A%2F%2Fwww.chop.edu%2F&a=Children%27s+Hospital+of+Philadelphia(CHOP) has been elected to the National Academy of [...]

FREMONT, Calif., Oct. 21, 2024 /PRNewswire/ -- nCartes, Inc, a leader in EHR-to-EDC clinical trial data fulfillment, has gone live with its REDCap EDC integration capability in collaboration with UC [...]

PHILADELPHIA, Oct. 18, 2024 /PRNewswire/ -- In a study conducted at Hospital for Special Surgery (HSS), researchers found that patients with obstructive sleep apnea (OSA) who used continuous positive airway [...]

DELRAY BEACH, Fla., Oct. 18, 2024 /PRNewswire/ -- The global https://www.marketsandmarkets.com/Market-Reports/pain-management-devices-market-91418163.html?utm_source=prnewswire.com&utm_medium=paidpr&utm_campaign=painmanagementdevicesmarket is expected to grow to USD 5,835.8 Million by 2029, up from USD 3,768.6 Million in 2024, at a [...]

ORCHARD PARK, N.Y., Oct. 18, 2024 /PRNewswire/ -- In honor of Mentholatum's 135th anniversary, the company proudly announces the launch ofMentholatumHeel Revival Cream , a groundbreaking solution for persistent cracked [...]

Results of the first season of a randomized study showed adjuvanted and high-dose influenza vaccines did not differ in effectiveness against PCR-confirmed influenza. This is the first randomized study to [...]

SAN FRANCISCO, Oct. 17, 2024 /PRNewswire/ -- AusperBio Therapeutic, Inc. and Ausper Biopharma Co., Ltd. (togetherAusperBio ), a clinical-stage biotechnology company, today announced that new clinical data from its lead [...]

In this free webinar, learn about the advantages and challenges of conducting clinical research in Africa. Attendees will learn how to enhance patient recruitment by accessing diverse and accessible populations. [...]

Explore DCN Dx's contract IVD services and customizable lateral flow reader at Booth Hall 3 / D25-2 CARLSBAD, Calif., Oct. 17, 2024 /PRNewswire/ -- DCN Dx, a global leader in [...]

In this free webinar, learn about the importance of pandemic preparedness and how it can be achieved. Attendees will learn what it takes to manufacture pharmaceutical products and launch clinical [...]

NEW YORK, Oct. 17, 2024 /PRNewswire/ -- Thousands of passionate people with lupus and those who care about the cause will join together Saturday, October 19 at the Intrepid Museum [...]

WILMINGTON, Del., Oct. 17, 2024 /PRNewswire/ -- IgniteData, a company focused on healthcare technology solutions, announces a new collaboration with Mayo Clinic to deploy its Archer platform across multiple sites [...]

Findings offer new insights with potential to inform diagnosis and treatment PHILADELPHIA, Oct. 16, 2024 /PRNewswire/ -- Researchers at https://c212.net/c/link/?t=0&l=en&o=4279814-1&h=2041330083&u=http%3A%2F%2Fwww.chop.edu%2F&a=Children%27s+Hospital+of+Philadelphia(CHOP) announced the results of a new study highlighting significant genetic [...]

US FLUBLOK label[sup.1] updated to incorporate new safety study in pregnant individuals New safety data involving more than 48,000 pregnant individuals published in American Journal of Obstetrics and Gynecology (AJOG) [...]

RALEIGH, N.C., Oct. 16, 2024 /PRNewswire/ -- Eximia Research, an integrated clinical trial network, has acquired Integrated Clinical Trial Services, Inc. (ICTS). With this expansion into Iowa, this partnership marks [...]

Experienced Sales Leader to Drive Revenue Growth as ObvioHealth Transitions to Enterprise Solutions NEW YORK, Oct. 16, 2024 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=4279065-1&h=2777905297&u=https%3A%2F%2Fwww.obviohealth.com%2F&a=ObvioHealth, a global leader in digital clinical trial solutions, announces [...]

In this free webinar, gain insights into protocol digitization, understand how it can drive efficiencies and discover how it can elevate clinical trials. Attendees will learn about the value of [...]

BRIDGEWATER, N.J., Oct. 16, 2024 /PRNewswire/ -- Sanofi announced today it will contribute $18 million to three Historically Black Medical Schools to help the institutions work to increase diversity in [...]

Grant will lead to the creation of USDHub, a novel research tool bringing together research and clinical data from hundreds of thousands of kidney stone patients of all ages PHILADELPHIA, [...]

PHILADELPHIA, Oct. 15, 2024 /PRNewswire/ -- In honor of World Thrombosis Day, the National Blood Clot Alliance ('NBCA'), the nation's leading patient advocacy organization dedicated to advancing the prevention, early [...]

Publication of Eupraxia's Phase 2b data in Lancet Rheumatology, a distinguished and respected journal, raises the profile of EP-104IAR. As outlined in Lancet Rheumatology, Eupraxia's EP-104IAR imparts clinically significant and [...]

After 24 weeks of treatment in patients with Type 2 diabetes, the bi-weekly GLP-1 receptor agonist GZR18 injection showed superior efficacy in lowering HbA1c and body weight compared to semaglutide [...]

Achieving a Significant Clinical Milestone in Assessing the ReCET(TM) System as a Groundbreaking Treatment for Type 2 Diabetes MINNEAPOLIS, Oct. 15, 2024 /PRNewswire/ -- Endogenex, Inc., a clinical-stage medical device [...]

ISM-001 is a potential first-in-class antibody that may lead to a new treatment pathway for patients with peripheral arterial disease (PAD)Company enters strategic collaboration with Pfizer Ignite to accelerate IND-enabling [...]

NEW YORK, Oct. 15, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative treatments, is proud to announce the granting of a U.S. [...]

TAIPEI and SAN DIEGO, Oct. 14, 2024 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today [...]

The Merlin test (CP-GEP) stratifies melanoma patients based on risk for sentinel lymph node (SLN) metastasis, offering a powerful tool for risk-based decision-making. ROTTERDAM, Netherlands and SAN DIEGO, Oct. 13, [...]

First scientific presentation of previously announced data from Cohort 1 of the ongoing Phase 1b clinical trial evaluating low-dose LTI-03 (2.5 mg BID) in IPF, affirms positive trends in seven [...]

CORK, Ireland, Oct. 11, 2024 /PRNewswire/ -- OrthoXel is excited to announce that Hannah Dailey PhD (Co-Founder & CSO of OrthoXel), will present clinical research on 'Micromotion Nailing for Accelerated [...]

In this free webinar, learn how an adaptable functional service provider (FSP) is essential to sponsors and large clinical research organizations in drug development. Attendees will explore why flexibility is [...]

Seasoned Healthcare Executive Nicholas Campbell Joins ObvioHealth Board of Directorsto Drive Digital Innovation in Clinical Trials NEW YORK, Oct. 10, 2024 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=4274826-1&h=3425737361&u=http%3A%2F%2Fwww.obviohealth.com%2F&a=ObvioHealth, a leading digital health company revolutionizing [...]